Skip to main content
. 2020 Aug 18;8(8):1250. doi: 10.3390/microorganisms8081250

Figure 5.

Figure 5

Some peptidic inhibitors of SARS-CoV-2. Structures and their half maximal inhibitory concentration values/ half-maximal effective concentration (IC50s/EC50s) against SARS-CoV-2 3CLpro are shown. The binding site 11a with SARS-CoV-2 3CLpro is shown. The inhibitor 11a is shown as sticks, and the protease is shown as a surface. S1 and S2 indicate the binding sites for P1 and P2 residues of the inhibitor.